A comprehensive view of Immune System Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
US Patent Issued to Bristol-Myers Squibb on April 23 for "Substituted bicyclic compounds useful as T cell activators" (American, Indian Inventors)
Published:
April 24, 2024
by U.S. Fed News
|
US Patent Issued to Amgen on April 23 for "ST2 antigen binding proteins" (American, Canadian Inventors)
Published:
April 24, 2024
by U.S. Fed News
|
US Patent Issued to PFIZER on April 23 for "Modulators of STING (stimulator of interferon genes)" (California, Connecticut Inventors)
Published:
April 24, 2024
by U.S. Fed News
|
Sanofi's rilzabrutinib meets primary endpoint in Phase 3 LUNA 3 study for immune thrombocytopenia; potential for clinically beneficial treatment of several immune diseases underscored, with regulatory submissions in the US and EU expected by year-end
Published:
April 23, 2024
by Sanofi SA
|
Mount Sinai researchers identify how a family of proteins activate immune cells related to inflammatory bowel disease; discovery may potentially lead to new treatments for conditions such as ulcerative colitis and Crohn's disease
Published:
April 22, 2024
by Newswise - SciNews
|
Ask us about our Health Care Sector market view